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ABSTRACT Long-term potentiation in the CAl region of
the hippocpus, a model for memory formation in the brain,
Is diided into two phases. A transient process (induction) is
initiated, which then generates a persistent mechanism (main-
tenance) for enhancing synaptic strenth. Protein kinase C
(PKC), a gene family of multiple isozymes, may play a role in
both induction and maintenance. In region CAl from rat
hippocampal sices, most of the isozymes ofPKC translocated
to the partcuate fraction 15 sec after a tetanus. The Increase
of PKC in the particulate fraction did not persist into the
maintenance phase of long-term potentiation. In contrast, a
constitutivey active kinase, PKM, a form specific to a single
isozyme (), increased in the cytosol during the maintenance
phase. The tramition from trnslocation of PKC to formation
of PKM may help to explain the molecular mechanims of
induction and maintenance of long-term potentiation.
During long-term potentiation (LTP), the tetanization of syn-
aptic afferents initiates a sustained enhancement of synaptic
transmission. Enzymes that participate in signal transduction
and the regulation of synaptic strength may be persistently
active during the maintenance ofLTP (1) and could contribute
to the underlying mechanism ofmemory (2). In the CAl region
of the hippocampus, the induction of LTP begins with the
influx of Ca2+ into the postsynaptic neuron (3, 4) through the
activated N-methyl-D-aspartate (NMDA) receptor (5, 6). Be-
yond that step, several protein kinases have been implicated
in the induction of LTP (7-10), including protein kinase C
(PKC). PKC may also have a role in the maintenance ofLTP,
since activators ofPKC such as phorbol esters cause synaptic
potentiation (11) and inhibitors ofprotein kinase activity such
as H7 (1, 12) or pseudosubstrate peptides (13) may block
expression of LTP, although their effects have not been
consistent (7, 14). The multiple roles of the enzyme during
induction and maintenance might be explained by the heter-
ogeneity of PKC isozymes in brain (15).
The activation ofPKC by second messengers is believed to
involve the translocation of the enzyme, in which elevations
of diacylglycerol or applications of phorbol esters shift the
distribution of PKC to membrane (16). However, a second
mechanism of PKC activation in which the kinase becomes
independent of second messengers has been demonstrated,
primarily in vitro. Proteolytic cleavage between the N-ter-
minal regulatory domain and the C-terminal catalytic domain
generates an independent constitutively active fragment,
termedPKM (17) (Fig. 1A). When Ca2+ chelators are omitted
during homogenization of brain tissue, a 51-kDa PKM is
formed by the activation of Ca2+-dependent proteases
calpains (17). Endogenous PKM has been shown to occur in
a tumor celi line (18). However, despite the appeal of the
notion of a persistently active form of PKC in neuronal
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function, to our knowledge, the presence of endogenous
PKM in brain has not been previously described.
MATERIALS AND METHODS
Preparation of Hippocampal Slices. After anaesthesia with
halothane, transverse 450-;Lm hippocampal slices from 3- to
4-week-old Sprague-Dawley rats were prepared with a McII-
wain tissue slicer. For biochemical experiments or after
pharmacological or electrical stimulations, the slices were
frozen by contact with a metal rod cooled to -55°C. The
slices were then transferred to propylene glycol/0.9M NaCl,
1:1 (vol/vol), for dissection of CAl regions on powdered dry
ice. Pooled CAl regions were washed twice at 4°C in ho-
mogenization buffer [50 mM Tris-HCl, pH 7.5/1 mM
EDTA/1 mM EGTA/5 mM 2-mercaptoethanol/0.1 mM phe-
nylmethylsulfonyl fluoride/aprotinin (17 kallikrein units/
ml)/5 mM benzamidine/0.1 mM leupeptin (unless otherwise
specified, chemicals were from Sigma)]. Four to five CAl
regions were homogenized in 300 Al of the buffer by 15
strokes of a Teflon-glass Potter-Elvehjem tissue grinder
(Kontes) and centrifuged at 3000 x g for 5 min to remove
unhomogenized material and nuclei (P1). The supernatant(Si) was centrifuged again at 100,000 x g for 30 min to
produce a supernatant (S2, cytosolic fraction) and pellet (P2,
particulate fraction). A typical yield oftotal protein was 50 pg
from S2 and 15 pug from P2. Protein was determined by a
modification of the Bradford assay (19, 20), except for slices
comparing homogenization techniques with boiling in SDS/
sample buffer (100°C for 10 min) without fractionation, which
were determined by assay using bicinchoninic acid (Pierce).
PKC LIozyme-Specific Antisera. Isozyme-specific rabbit
antisera were prepared by injection of maleimide-activated
bovine serum albumin (Pierce) conjugated to peptides cor-
responding to the C-terminal regions of PKC isoforms (a,
PQFVHPILQSAV; (3I, SYTNPEFVINV; 31I1, SFVNSE-
FLKPEVKS; y, PDARSPTSPVPVPVM; 8, NPKYEQFLE;
e, YFGEDLMP; 4, EYINPLLLSAEESV). The antisera
were affinity-purified on columns in which the peptides had
been conjugated to SulfoLink coupling gel (Pierce). Immu-
noblots (21) ofSDS/8% polyacrylamide gels (22) were in the
linear range of detection, using either alkaline phosphatase
(Promega) or chemiluminescence (Amersham) detection
methods. The levels of PKC isozymes from fractions of
hippocampal slices were compared by loading equal amounts
oftotal protein from the fractions on the gel. Densitometry of
bands was performed with National Institutes of Health
Image software on an XRS 6cx scanner (OmniMedia, Tor-
rance, CA). For experiments demonstrating specificity ofthe
primary antibody, the antiserum was preincubated for 2 hr at
Abbreviations: PKC, protein kinase C; LTP, long-term potentiation;
EPSP, excitatory postsynaptic potential; NMDA, N-methyl-D-
aspartate; CPP, 3-[(RS)-2-carboxypiperazin-4-yl]-propyl-1-phos-
phonic acid.
*To whom reprint requests should be addressed.
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FIG. 1. PKC and PKM family of protein kinases in the hippocampus. (A) Schematic diagram ofPKC and PKM prototypes. PKC contains
a regulatory domain and a catalytic domain, separated by a hinge region (H). PKM is the independent C-terminal region generated by proteolytic
cleavage at the hinge. Isozyme-specific antisera were made to the C-terminal variable regions (V) to detect bothPKC and PKM. (B) Immunoblot
of hippocampal proteins from CAl (6 pg of protein per cm-lane) with affinity-purified PKC isozyme-specific antisera. Single bands or doublets
are detected with most ofthe antisera. Antiserum to the C-terminal region of Cdetects three major proteins. Positions ofmolecularmass standards
inkDa are shown on the left. (C) Peptide mapping. The peptide maps ofthe 51-kDa and 70-kDaproteins produced by CNBrcleavage are identical.
Cleavage products were detected on an immunoblot with C-terminal ; antiserum. Molecular masses of all the cleavage products are given in
the text. Positions of molecular mass standards are shown at left. (D) Immunokinase assay. An autoradiogram shows autophosphorylation of
a 51-kDa protein immunoprecipitated by the ; antiserum. Specificity of the assay is demonstrated by preincubating the antiserum with the
immunizing peptide (lane +). (E) Phorbol esters (5 pM phorbol 12,13-dibutyrate for 30 min) cause the translocation to the particulate fraction
ofall isozymes ofPKC. Levels ofisozymes in the particulate fraction from CAl regions ofhippocampal slices treated with phorbol are compared
to levels from control slices from the same hippocampus set to 100o (mean + SEM; n = 8; n values in this and other experiments represent
separate animals). Levels ofPKC in the particulate fraction with or without phorbol treatment were evaluated by multiple analysis of variance.
The following effects were significant (P < 0.05): between isozymes [F(7,gl) = 4.50], between treated and nontreated [F(l1,l) = 37.81], and the
interaction ofisozyme and treatment condition-i.e., the patterns ofchange varied by isozyme [F(7,sl) = 2.89]. The effect ofphorbol on individualisozymes was then evaluated by paired t test. *, For this and other figures, when experimental groups are compared to control, P < 0.05.
25°C in 50 Au ofbovine serum albumin (Calbiochem; 1 mg/ml)
in the presence or absence of 20 pg of immunizing peptide.
Antiserum to the C-terminal peptide of PKCfl was a
generous gift from Shin-ichi Osada (Yokohama University)
(23). This antiserum detected the primarily lung- and skin-
specific isozyme (82 kDa) at very low levels in brain. The
antiserum did detect in brain, however, a prominent protein
of 97 kDa that has properties of PKC (24).
Peptide Mapping. CNBr cleavage (25) was performed by
excision and electroelution of proteins from an SDS/8%
polyacrylamide gel and incubation for 24 hr with CNBr (3
mg/ml) in 70% (vol/vol) formic acid. After lyophilization, the
C-terminal peptides were separated on aSDS/15% polyacryl-
amide gel and detected on immunoblots with the Cantiserum.
Autophosphorylaton. Autophosphorylation ofthe material
immunoprecipitated by the C antiserum (immunokinase as-
say) was initiated by incubation of 50 pg of the S2 hippo-
campal fraction (in 200 of the homogenization buffer/150
mM NaCl, without 2-mercaptoethanol) and 1 1/ of ; antise-
rum for 2 hr at 4°C. After a 1-hr incubation with protein
A-Sepharose beads (25 id, Pharmacia), the immunocom-
plexes were centrifuged (1000 x g for 30 sec) and washed with
the buffer three times. The pellet was then resuspended in 40
/1 of reaction mixture (50 mM Tris-HCl, pH 7.5/10 mM
MgCl2/1 mM 2-mercaptoethanol/1 mM pyrophosphate), and
autophosphorylation was begun by the addition of 10 id of[t-32P]ATP (1 juCi per assay mixture at a final concentration
of 1 ,uM; 1 Ci = 37 GBq). After 5 min at 30°C, the reaction
was stopped by the addition of 50 /1 of 1 mM unlabeled ATP
and sample buffer. The autophosphorylated proteins, sepa-
rated on an SDS/8% polyacrylamide gel and transblotted to
nitrocellulose, were detected by autoradiography with
X-AR5 film (Eastman Kodak).
For dilution experiments, the autophosphorylation of
PKMC was determined in solution rather than using PKMC
attached to beads. PKMC was parially purified by loading
200 pg of the S2 hippocampal fraction (without 2-mercapto-
ethanol) onto a DEAE-cellulose column (Millipore) that had
been equilibrated with 50 mM Tris-HCl, pH 7.5/1 mM
EDTA/1 mM EGTA. The column was washed with 200 mM
NaCl (to remove most of the other PKCs) and PKMC was
eluted with 400 mM NaCl. The salt was diluted in equilibra-
tion buffer and the sample was concentrated with a micro-
concentrator (Amicon). The 400 mM fraction was serially
diluted 1:20 and autophosphorylation was performed as
above, except 6.25 uCi per assay mixture was used. Auto-
phosphorylation ofthe fraction enriched forPKMC showed a
single major band comigrating with PKM4, which in parallel
experiments immunoprecipitated with the Cantiserum. Phos-
phate incorporation was quantitated by scintillation counting
of the excised bands.
Tetanization. Slices were placed in an interface recording
chamber infused initially with a saline solution (125 mM
NaCl/2.5 mM KCl/1.25 mM NaH2PO4/26 mM NaHCO3/11
mM glucose, pH 7.4) containing 10 mM MgC12 and 0.5 mM
CaCk2, equilibrated with 95% 02/5% CO2 at 32°C. This
A
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concentration ofMgCl2 has been shown to help preserve CAl
pyramidal cells after slice preparation (26). After 1 hr, the
divalent ion concentrations were changed to 1.2 mM MgCl2
and 1.7 mM CaCl2. Test stimuli of 100-isec pulse duration
were delivered every 15 sec to the Schaffer collateral/
commissural fibers through a bipolar tungsten electrode. The
current was set to produce 30% of the maximal population
spike amplitude, typically 300-600 ,uA, as determined by an
input-output curve for each slice. Extracellular recordings
were made with standard glass electrodes containing 2 M
NaCl that were placed in the CAl pyramidal cell layer
(population spikes) or stratum radiatum [field excitatory
postsynaptic potentials (EPSPs)]. After at least 15 min of
stable recording, a tetanus of 100 Hz for 1 sec was given. The
current of the tetanic stimuli was set to produce 75% of the
maximal population spike amplitude. Determination of the
slope of the initial phase of the extracellular EPSP and the
population spike amplitude was performed with SuperScope
(GW Instruments, Somerville, MA).
RESULTS
Characterization ofPKC Isozymes and the PKM Form of the
CIsozyme in Hippocampus. By immunoblot analysis, most of
the antisera to the individual isozymes of PKC detected
single major bands or doublets of appropriate molecular mass
based upon the corresponding predicted amino acid se-
quences (Fig. 1B). The molecular masses were as follows: a,
80 kDa; (3I, 77 kDa; (3I1, 79 kDa; y, 79 kDa; 8, 76 kDa; E, 89
kDa; {, 70 kDa; q-related isoform, 97 kDa. The antiserum to
PKC4, which has a predicted molecular mass of -68 kDa
(27), however, detected three major proteins of 160, 70, and
51 kDa. Occasionally, a minor band of 80 kDa was also
detected (data not shown). Antiserum binding to all three
major proteins was blocked by preincubation of the antise-
rum with the immunizing peptide (data not shown).
To confirm that the 51- and 70-kDa proteins are structurally
related, peptide maps of the two proteins were generated by
CNBr cleavage. The molecular masses of the cleavage prod-
ucts of the two proteins, detected on immunoblot with the
C-terminal ; antiserum, were identical (Fig. 1C). The mo-
lecular masses of the C-terminal CNBr fragments predicted
by the published amino acid sequence of PKCC (27) are as
follows: 15.3, 17.0, 17.1, 17.6, 22.3, 28.8, 29.3, and 36.1 kDa.
The observed molecular masses of the fragments are as
follows: 15.5, 17.0, 20.5, 22.6, 23.8, 25.2, 28.0, 29.9, 32.0, and
35.5 kDa. Variations in the sizes of the observed fragments
may be due to phosphorylation. This result suggests that the
51-kDa protein is related to the C-terminal region of the
70-kDa protein.
We then characterized the catalytic activity of the 51-kDa
{-related protein by immunokinase assay. The Cantiserum
immunoprecipitated from an extract of hippocampus a single
major autophosphorylating protein, comigrating with the
51-kDa protein (Fig. ID). Preincubation ofthe antiserum with
the immunizing peptide inhibited the precipitation of the
kinase. Phosphorylation of the 51-kDa substrate was linear
for 30 min and was not increased by addition of phosphati-
dylserine or phorbol esters (data not shown). To confirm that
the phosphorylation was intramolecular, the specific activity
of the phosphorylation with serial dilution of the 51-kDa
protein was determined at an initial reaction rate and with
ATP concentration constant. The specific activity remained
constant with dilution, and a plot ofthe logarithm ofthe initial
velocity vs. the logarithm of the enzyme concentration (a
van't Hoff's plot of the data, not shown) (28) was found to be
linear with a slope of 1.00 (n = 2). These results indicate an
intramolecular phosphorylation of the 51-kDa protein and, in
combination with the peptide mapping, suggest that the
51-kDa protein detected by the ;antiserum is the PKM form
of the isozyme (PKMO).
Although none of the other antisera detected major pro-
teins of appropriate molecular mass for PKM in hippocampal
slices (potential PKM forms of other isozymes were occa-
sionally detected as minor bands, data not shown), we wished
to determine whether PKM;was formed during our homog-
enization and fractionation of untreated slices. Immunoblots
from hippocampal slices that were homogenized in the pres-
ence of a combination ofprotease inhibitors and 1 mM EGTA
(our usual procedure) were compared to slices that were (i)
boiled immediately after dissection in SDS/sample buffer,
which rapidly denatures cellular proteins; (ii) homogenized
with 20 mM EGTA and protease inhibitors including 1 mM
leupeptin (10 times our usual concentration); or (iii) prein-
cubated for 30 min with a cell-permeable protease inhibitor,
the leupeptin analogue Cbz-Val-Phe at 100 ,uM (where Cbz is
carbobenzoxy, a gift from Shujaath Mehdi and Ekkehard
Bohme, Marion Merrell Dow) (29). Relative to our normal
homogenization procedure, the levels of total PKMC using
the alternative conditions were 106.6 ± 3.2%, 94.8 ± 5.9%6,
and 95.7 ± 8.9%o, respectively (mean ± SEM; n = 3).
Therefore, none of these alternative homogenization proce-
dures significantly altered the levels ofPKMC. We also found
PKMC in hippocampus homogenized whole without slicing
on a tissue chopper and in organotypic hippocampal slice
cultures boiled in SDS/sample buffer (data not shown).
In preparation for physiological experiments, applications
of phorbol esters (5 ,uM phorbol 12,13-dibutyrate for 30 min)
were shown to increase all isoforms ofPKC, including PKCC,
in the particulate fractions of the CAl regions from hippo-
campal slices, as compared to levels in CAl regions from
untreated slices (Fig. 1E). [Although purified or overex-
pressed PKC? does not bind phorbol esters in vitro (27, 30),
the agent, when applied to cells such as platelets (31) or
fibroblasts (32), can result in translocation of the endogenous
isozyme.]
PKC Iszymes in LTP. To determine whether PKC, or a
subset of isozymes, is activated during the induction phase of
LTP, we measured the shift in subcellular distribution ofeach
isozyme in region CAl of hippocampal slices 15 sec after a
single tetanus (100 Hz for 1 sec) to Schaffer collateral/
commissural fibers. [In parallel experiments, the tetanus
resulted in long-lasting potentiation in 85% of slices (Fig. 2A
and B).] Fifteen seconds after the tetanization, a, (i, (II, 8,
4, and n-related isoforms increased significantly in the par-
ticulate fraction (Fig. 2C).
We next examined whether the maintenance of LTP in
CAl was related to persistence of the increase of PKC in the
particulate fraction. Slices that showed stable potentiations
of population spike amplitude and extracellular EPSP slope
(279.3 ± 20.7% and 168.3 ± 9.3% of baseline, respectively)
30 min after a tetanus were compared to adjacent slices that
had stable recordings but were not tetanized. In the mainte-
nance phase of LTP, the levels of all the isozymes of PKC in
the particulate fraction of CAl were no longer elevated (Fig.
2D).
PKMC in LTP. Since PKC isozymes did not persistently
translocate to membrane, we wished to know whether there
was a change in the level of the PKM form of ; that might
account for the maintenance of LTP. No change in PKMC
level was observed with either applications of phorbol esters
(95.4 ± 7.8% of control levels of S2; n = 8) or 15 sec after
tetanization (89.3 ± 7.1%; n = 6). However, 30 min after the
tetanization, PKMC in the cytosol increased significantly(141.2 + 14.8%; n = 11; paired ttest, P < 0.05; Fig. 3). PKMt
could also be detected in the particulate fraction, but the level
did not consistently increase 30 min after tetanization (data
not shown).
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FiG. 2. Effects of tetanization on PKC in the particulate fraction from region CAl of the hippocampus. (A) Representative field EPSPs,
pretetanus and 30 min posttetanus. The stimulus artifacts are shown by the arrowheads. (B) LTP, showing a persistent increase in initial slope
ofextraceliular EPSPs for 30 min after a tetanus (arrow). A representative experiment is shown; mean potentiation is given in text. (C) Increase
ofPKC isozymes in the particulate fraction 15 sec after tetanization. Comparisons were made to control levels ofPKC in the particulate fraction
from adjacent slices of the same hippocampus (n = 6). The translocation was analyzed by a one-way analysis of covariance of the levels ofeach
isozyme, adjusting for the control values. The analysis showed significant differences among the isozymes [F(7,49) = 2.87, P < 0.02],demonstrating that the data are not random. The changes due to tetanization were then examined separately for each isozyme by paired t test.
(D) The increase of PKC in the particulate fraction does not persist 30 min after tetanus. Tetanized slices showed stable recordings for 15 mi
prior to tetanization and LTP for 30 min. Control levels ofPKC in the particulate fraction were from adjacent slices that showed stable recordings
for45min(n = 11).
We next examined whether the formation ofPKMCin slices
showing LTP at 30 min might have occurred in vitro during
homogenization and fractionation by a protease activated by
tetanization, despite the presence of protease inhibitors ade-
quate for untetanized slices. We first found that the yield of
PKMC by our usual homogenization and fractionation of
tetanized slices was identical [98.0 ± 9.7% (n = 3)] to that from
other tetanized slices from the same hippocampus that had
been boiled (without fractionating) in SDS/sample buffer. We
next boiled both tetanized and untetanized slices in SDS and
found that the level of PKMC in the tetanized slices was
significantly greater than in the controls (123.6 ± 10.1%; n =
6; paired t test, P < 0.05). Since whole tissue boiled in SDS
contains the sum of the proteins in the subceliular fractions
(P1, P2, and S2), this increase in PKMCis consistent with the
larger increase seen in the S2 fraction alone.
To determine the role ofNMDA-receptor activation in the
formation of PKM4, we applied the NMDA-receptor antag-
onist, 3-[(RS)-2-carboxypiperazin4yl]-propyl-1 phosphonic
acid (CPP, 10 jAM; Tocris Neuramin, Bristol, U.K.) during
the experiment. CPP prevented the long-lasting synaptic
potentiation (98 ± 2.9%; Fig. 4A) and the increase in PKMC
(99.5 ± 9.1%, n = 4; Fig. 3). No change was seen in levels of
PKC in the particulate fraction at 30 min (Fig. 4B).
DISCUSSION
PKC appears to be activated during the induction and main-
tenance phases of LTP, but by different molecular mecha-
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PKM;, assayed 30 min after tetanization. (B) PKM; from immuno-
blots (representative of the experiments described in A). Tetanus
lanes: -, from control CAl that was recorded at low frequency but
not tetanized; +, from CAl 30 min after tetanization. CPP lanes: -,
not added; +, added. CPP blocks the formation of PKM{.
nisms. A transient translocation ofPKC isozymes occurs in
the induction phase, followed by a persistent increase in the
PKM form of a single isozyme, {, in the maintenance phase.
In the induction phase, both Ca2+-dependent and Ca2+-
independent isozymes are responding to second messengers,
presumably Ca2+ and lipid second messengers produced by
phospholipases (33). This initial translocation could prime the
enzyme for the formation ofconstitutively active PKM, since
membrane-bound PKC is particularly sensitive to proteolysis
(34) (Fig. 4C). We speculate that the NMDA-mediated acti-
vation of proteases such as calpains (35, 36) may have
contributed to a loss ofPKC at the membrane and a proteo-
lytic formation of PKMC that we observed at 30 min. Ac-
cording to this model, the catalytic domain of the ; isoform
would be selectively stable, protected from complete prote-
olysis that affects the other PKC isoforms. Alternatively,
PKMCmay be a gene product related to PKCC that increases
during the maintenance phase of LTP. Although the mech-
anism ofPKMC formation could be pre- or posttranslational,
the latter is supported by evidence that applications of
protease inhibitors, particularly those that affect calpains,
inhibit the formation of LTP maintenance (37).
While the mechanism of its formation remains to be
elucidated, the increase in PKMC is consistent with previous
reports that a persistent kinase activity, likely to be related to
PKC, is present during (38) and necessary for (1, 12, 13) the
maintenance of LTP. Although purified PKCC has been
reported to have some activity even in the absence of lipids
(27), the level of constitutive phosphotransferase activity of
PKCCis -15% ofthe activity ofthePKM form ofthe isozyme
(39). Therefore, a conversion from PKCC to PKMC would
result in a large increase in constitutive activity persisting in
the maintenance phase of LTP. Our findings are consistent
with those of Klann et al. (38), who report that the persistent
kinase activity toward exogenous PKC substrates does not
require diacylglycerol, Ca2+, or phosphatidylserine. Further-
more, the transition from translocation ofPKC to formation
ofPKM may explain why inhibitors of hydrophobic interac-
tions (e.g., sphingosine and polymyxin B), which affect
regulatory domains of some enzymes, including PKC, be-
come ineffective in blocking LTP after the initial phase ofthe
potentiation (1, 12).
Our results differ, however, from a previous study by
Akers et al. (40) on LTP by perforant-path stimulation, in
which a persistent translocation of PKC was reported. The
difference may be due to the method of induction, the
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R. K. S. Wong for advice on recording from hippocampalslices; and
A. Geller for his technical assistance. This study was supported by
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FiG. 4. NMDA-receptor activation is necessary for the persis-
tence ofPKC activation. (A) CPP (10 AM) in the bath blocks LTP of
field EPSPs after a tetanus (arrow). A representative experiment is
shown. (B) Thirty minutes aftertetanization, PKC levels in the
particulate fraction are equal to control levels fromuntetanized slices
(n = 4). (C) Schematic representation of roles of PKC and PKM in
LTP. After an initial translocation of multiple PKC isozymes to
membrane, a persistently active form of the enzyme, PKM, specific
to a single isozyme, C, increases in the maintenance phase. We
speculate that the intermediate signal transduction events may occur
as follows: (i) During induction, Ca2+ entering through NMDA
receptors (rec) activates phospholipases (PL), which stimulate the
production of lipid second messengers (L). Inactive cytosolic PKC,
containin a egulatory (reg) and a catalytic (cat) domain, translocates
tomembrane during the induction phaseimmiately after synaptic
activation. (ii) The translocation serves to activate the enzyme,
priming it for proteolysis. (iii) In themaintenanc phase ofLTP, most
of the membrane-bound PKCs are proteolytically degraded. The{
isoform undergoeslimited proteolysis of its regulatory domain toform
PKMC, which is independent of second messenger stimulation.
synaptic locus of the potentiation, or the region that was
assayed (the entire dorsal hippocampus in Akers' compared
to the isolated CAl in our experiments).
Persistence of protein kinase activity through the loss of
regulation by second messengers has been proposed as a
molecular mechanism for memory (2). Examples are the
persistence of cAMP-dependent protein kinase activity dur-
ing long-term sensitization in Aplysia through proteolysis of
the enzyme's regulatory subunit (41) and the autoactivation
of the Ca2+/calmodulin-dependent protein kinase by auto-
phosphorylation (42, 43). Studies ofLTP may provide insight
into the role such a molecular mechanism plays in physio-
logical long-term synaptic enhancement in the hippocampus.
For PKC, our results indicate that the molecular mechanism
for persistence is specific to the maintenance phase of the
potentiation and to a single isoform of the enzyme.
We thank Drs. W. Sossin and M. Osman for their assistance in the
production of antisera; S.-i. Osada for antiserum to PKC71; P.
Bergold for organotypic hippocampal slice cultures; M. Makowske
for helpful discussions; I. Kupferman for reading the manuscript; R.
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